Research output per year
Research output per year
Personal profile
Biography
Dr. Willem (Joost) Lesterhuis is an NHMRC EL2 Investigator, a Simon Lee Fellow and an Adjunct Associate Professor at the University of Western Australia. Dr Lesterhuis is Program Head Cancer Reseach at the Telethon Kids Institute, where he leads the Sarcoma Translational Research team. He has a background as a dual-trained medical oncologist and basic researcher in tumour immunology and cancer biology.
Dr Lesterhuis' research sits at the crossroads of tumour immunology, cancer biology, drug discovery and systems biology, with a particular focus on sarcoma.
Research
Current research projects include:
- Developing local immunotherapeutic approaches to treat sarcoma
- Unravelling the cellular and molecular processes that govern successful immunotherapy-induced cancer regression
- Combining chemotherapy and immunotherapy to treat cancer
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Industry keywords
- Drug Discovery
- Medicine and Pharma
Research expertise keywords
- Cancer immunology
- Immunotherapy
- Drug development
- Biomarkers
Fingerprint
Dive into the research topics where Willem Lesterhuis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy
Chin, W. L., Cook, A. M., Chee, J., Principe, N., Hoang, T. S., Kidman, J., Hmon, K. P. W., Yeow, Y., Jones, M. E., Hou, R., Denisenko, E., McDonnell, A. M., Hon, C. C., Moody, J., Anderson, D., Yip, S., Cummins, M. M., Stockler, M. R., Kok, P. S. & Brown, C. & 10 others, , 21 Jan 2025, In: Cell Reports Medicine. 6, 1, p. 1-18 18 p., 101882.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade
Principe, N., Phung, A. L., Stevens, K. L. P., Elaskalani, O., Wylie, B., Tilsed, C. M., Sheikh, F., Orozco Morales, M. L., Kidman, J., Marcq, E., Fisher, S. A., Nowak, A. K., McDonnell, A. M., Lesterhuis, W. J. & Chee, J., 28 Sept 2024, In: Journal for immunotherapy of cancer. 12, 9, 15 p., e008568.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)23 Downloads (Pure) -
Exploiting temporal aspects of cancer immunotherapy
Zemek, R. M., Anagnostou, V., Pires da Silva, I., Long, G. V. & Lesterhuis, W. J., Jul 2024, In: Nature Reviews Cancer. 24, 7, p. 480-497 18 p.Research output: Contribution to journal › Review article › peer-review
20 Citations (Scopus) -
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
Kidman, J., Zemek, R. M., Sidhom, J. W., Correa, D., Principe, N., Sheikh, F., Fear, V. S., Forbes, C. A., Chopra, A., Boon, L., Zaitouny, A., de Jong, E., Holt, R. A., Jones, M., Millward, M. J., Lassmann, T., Forrest, A. R. R., Nowak, A. K., Watson, M. & Lake, R. A. & 2 others, , 26 Apr 2024, In: OncoImmunology. 13, 1, 14 p., 2345859.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade
Rwandamuriye, F. X., Wang, T., Zhang, H., Elaskalani, O., Kuster, J., Ye, X., Vitali, B., Schreurs, J., Orozco Morales, M. L., Norret, M., Evans, C. W., Zemek, R. M., Iyer, K. S., Lesterhuis, W. J. & Wylie, B., Aug 2024, In: OncoImmunology. 13, 1, 10 p., 2395067.Research output: Contribution to journal › Article › peer-review
Open Access
-
Paediatric Cancer Immunotherapy for Australia
Lesterhuis, W. (Investigator 01), Gottardo, N. (Investigator 02), Endersby, R. (Investigator 03), Kotecha, R. (Investigator 04), Cheung, L. (Investigator 05), Malinge, S. (Investigator 06), McDonnell, A. (Investigator 07) & Elaskalani, O. (Investigator 08)
Australian Lions Childhood Cancer Research Foundation (ALCCRF)
1/07/23 → 30/06/25
Project: Research
-
Kids are not small adults: identifying age-dependent drug targets in paediatric oncology
Endersby, R. (Investigator 01), Elaskalani, O. (Investigator 02), Wouters, M. (Investigator 03) & Lesterhuis, W. (Investigator 04)
Department of Health (Western Australia)
1/01/23 → 31/12/25
Project: Research
-
Small molecule drug in immuno-oncology
Lesterhuis, W. (Investigator 01) & Piggott, M. (Investigator 02)
Setonix Pharmaceuticals Pty Ltd
1/07/22 → 31/05/26
Project: Research
-
Intraoperative immunotherapy to prevent cancer recurrence after surgery (2.)
Lesterhuis, W. (Investigator 01), Veedu, R. (Investigator 02), Bond, C. (Investigator 03), Swaminatha Iyer, I. (Investigator 04) & Wang, T. (Investigator 05)
Department of Health (Western Australia)
28/06/22 → 27/06/25
Project: Research
-
Tipping the balance - improving response rates to cancer immunotherapy
Lesterhuis, W. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/21 → 31/12/25
Project: Research